Abstract:ObjectivesNon-invasive prenatal testing (NIPT) is utilized for screening the likelihood of fetal aneuploidy, presenting the benefits of non-invasiveness, high sensitivity, and specificity. Its application in prenatal screening has become ubiquitous. The inquiry into how pregnant women comprehend and determine NIPT screening strategies is paramount. Regrettably, there has been a dearth of research on this subject in China. Consequently, this study scrutinizes pregnant women’s cognizance and perspectives concerning NIPT, furnishing a foundation for advancing its judicious implementation.MethodsFrom February 2021 to December 2022, a questionnaire survey was conducted among pregnant women receiving prenatal care and screening at the Women’s Hospital, School of Medicine, Zhejiang University, who were randomly selected from a pool of individuals exhibiting a high risk of fetal aneuploidy on serological screening. The survey aimed to gather data on participant characteristics, knowledge, perception, and willingness concerning NIPT. The study employed chi-square and Kruskal Wallis tests to analyze subgroup differences.ResultsA total of 226 valid questionnaires were obtained. 83.2% of women pregnant women identified as high risk by serological screening would opt for NIPT, with 66.4% indicating that they would prefer NIPT for fetal aneuploidy screening in future pregnancies. These findings suggest a notable willingness among pregnant women to undergo NIPT. Additionally, the results suggest that various factors, including place of residence, educational level, family income, causes of abortion, and conception method, influence pregnant women’s knowledge about NIPT Accordingly, the level of NIPT knowledge varies among pregnant women.ConclusionThe survey generally revealed that pregnant women were strongly inclined to select NIPT; however, expectant Chinese mothers possess limited knowledge and perception regarding this screening method for fetal aneuploidy. Therefore, the government must implement effective measures to augment public awareness of fetal aneuploidy screening and encourage the judicious utilization of NIPT.

International experience of clinical practice of non-invasive prenatal testing

Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.

International experience of informed consent and genetic counseling on non-invasive prenatal testing applied in Down syndrome prenatal screening

Qualitative Analysis of Implementation and Governmental Regulation of Non-Invasive Prenatal Testing in China

Expanding the Scope of Non-invasive Prenatal Testing to Detect Fetal Chromosomal Copy Number Variations

Evidence of compliance with and effectiveness of guidelines for noninvasive prenatal testing in China: a retrospective study of 189,809 cases

Ethical considerations of non-invasive prenatal testing in Down syndrome prenatal clinical practice

Physicians' Perception Toward Non-Invasive Prenatal Testing Through the Eye of the Rogers' Diffusion of Innovation Theory in China

Understanding Knowledge, Perception, and Willingness of Non-Invasive Prenatal Testing for Fetal Aneuploidy: a Survey among Chinese High-Risk Pregnant Women

[Expert consensus on the clinical application strategy of NIPT2.0, a new-generation non-invasive prenatal screening technology]

The Knowledge, Attitude, Practices, and Satisfaction of Non-Invasive Prenatal Testing among Chinese Pregnant Women under Different Payment Schemes: A Comparative Study

Noninvasive Prenatal Testing (NIPT) in Twin Pregnancies with Treatment of Assisted Reproductive Techniques (ART) in a Single Center.

Positive predictive value estimates for noninvasive prenatal testing from data of a prenatal diagnosis laboratory and literature review

Performance evaluation of noninvasive prenatal testing on 24 chromosomes in a cohort of 118,969 pregnant women in Sichuan, China

[Perspective Study of Non-Invasive Prenatal Testing Using Cell-Free Fetal DNA in High-Risk Population].

Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China

Non-invasive prenatal testing for the diagnosis of congenital abnormalities: Insights from a large multicenter study in southern China

Non-Invasive Prenatal Testing (NIPT): Reliability, Challenges, and Future Directions

Situation analysis of prenatal diagnosis technology utilization in China: current situation, main issues, and policy implications

The performance evaluation of NIPT for fetal chromosome microdeletion/microduplication detection: a retrospective analysis of 68,588 Chinese cases

Advancements of non-invasive prenatal testing: the role of obstetricians